Impact of Liver and Whole-Body Diffusion-Weighted MRI for Neuroendocrine Tumors on Patient Management: A Pilot Study.
Fiche publication
Date publication
janvier 2017
Journal
Neuroendocrinology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume, Pr HOEFFEL Christine
Tous les auteurs :
Moryoussef F, de Mestier L, Belkebir M, Deguelte-Lardière S, Brixi H, Kianmanesh R, Hoeffel C, Cadiot G
Lien Pubmed
Résumé
Computed tomography scan is the current standard cross-sectional imaging modality for neuroendocrine tumor (NET) workup. Diffusion-weighted magnetic resonance imaging (DW-MRI) has proven to be more sensitive than standard sequences to diagnose liver metastases; whole-body DW-MRI may be more sensitive than whole-body MRI. Clinical implications have not yet been assessed. Thus, we evaluated radiological and clinical contributions of liver and whole-body DW-MRI to manage NETs.
Référence
Neuroendocrinology. 2017 ;104(3):264-272